Activation of the cell cycle pathway in response to MEK inhibition, evidenced by the increase of downstream effector proteins such as p-Rb, was found in cells with increased cell death and tumor shrinkage when MEK and CDK4,6 inhibitors were used. The gene discussed is RB1; the disease is neoplasm.